INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
about
Hereditary thrombophiliaPleiotropic effects of antithrombin strand 1C substitution mutationsDeficiency of protein C in congenital thrombotic diseaseGuidance for the evaluation and treatment of hereditary and acquired thrombophiliaCloning and expression of the cDNA for human antithrombin IIICoagulation abnormalities and cerebral infarctionBlood coagulation and its alterations in hemorrhagic and thrombotic disordersRisk associated with heparin withdrawal in ischaemic cerebrovascular diseaseDetermination of antithrombin activity by an amidolytic and a clotting procedure.Complete antithrombin deficiency in mice results in embryonic lethality.Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver").A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.Familial protein S deficiency is associated with recurrent thrombosis.Evidence-based approach to thrombophilia testing.In vitro and in vivo correlation of clotting protease activity: effect of heparin.Continuing education course #2: current understanding of hemostasis.Inherited trombophilic states and pulmonary embolism.Coagulation disorders seen through the window of molecular biology.Thrombophilia testing: what do we think the tests mean and what should we do with the results?The 3' end prothrombin gene variants in serbian patients with idiopathic thrombophilia.Heparin-binding domains in vascular biology.Thrombophilia - how far and how much to investigate?Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost.Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics.Symptomatic venous thromboembolism is a disease related to infection and immune dysfunctionEffect of danazol on the biochemical abnormality of inherited antithrombin III deficiencyThe prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation.Familial Clustering of Venous Thromboembolism - A Danish Nationwide Cohort StudyAntithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.Standardisation of a simple method for the determination of antithrombin activity.Isolation and sequence characterization of a cDNA clone of human antithrombin IIIAntithrombin-3 deficiency in a Dutch family.Thrombophilia: how far should a clotter be investigated?Familial venous thrombosis.Blood clotting and fibrinolysis in pregnancySerpins in thrombosis, hemostasis and fibrinolysisThe cost-benefit ratio of screening pregnant women for thrombophilia.
P2860
Q21093254-890A5A95-760B-4EFB-ABF4-D3531CB273DBQ24564590-AE1743C2-A654-4F4D-8E6E-CC4286B56466Q24600822-67C15283-ED0C-4553-813A-AFCE2B2A18D6Q28077943-DBB85854-33B4-4A90-8B17-9F1EA3579EC2Q28630962-1C026F6F-A8B7-4843-917B-634D63D36749Q33591061-D59AF81C-75F4-4D85-BA4A-5A1531F0F8F4Q33606686-24C384B5-4504-41D8-8B5F-70C3824B6422Q33627440-87A4CE79-F4EC-4917-95B2-159CEF627860Q33846856-24A8C11C-4411-4E36-92EF-245D24959502Q33920163-F315F8BB-4EF9-4AA8-B232-231E44E54C9BQ33954905-00DEF326-B775-40DA-801C-381AE67B9D67Q34527559-78A39E94-DA96-4F30-A8F5-BC29B8C654F0Q34560623-D9537B97-6582-4C94-803B-9350D9FC1338Q34611870-C187A5E9-1511-4017-842B-8A563A116EE6Q34622189-673BEFEA-5897-4E1B-9EFA-DABE0111A62EQ34663749-4826E09F-1DCC-4C33-929E-090C291F1831Q35038341-32100311-7CC8-4950-95C4-F4FFCCD33ADFQ35078025-047E27F9-2C53-4274-8CE9-BED22C3ABFF4Q35084785-6B978BA6-0B4C-4494-8916-90C9034F2706Q35199830-E8C6EBA2-0EE3-4D37-A195-316D8AF02D99Q35395839-1D7A837E-0B1A-45AF-9A94-6188AB9F1805Q35549649-1E24B6BE-0418-4322-87DA-BACA2AA1E290Q35825233-3F427D1C-050F-49F9-80C5-A9C967CEAE02Q35842854-55BCBB65-F390-425A-A3B8-00F5B1E982A9Q35966475-F5491BF5-C4BF-4702-9467-AD5C7205CA76Q36017106-F2BB7515-1EC1-464E-B163-01DA97FF2B22Q36101642-4C7C7C90-A1B8-45AC-B0B4-985860DE70C0Q36135083-EB356BA3-C243-4FDC-AACD-467E1B411820Q36148260-1FC2525D-F98E-4887-AB29-E58189D62C70Q36229803-28B53692-CAE3-4BED-BA3A-FF7DAC212863Q36235766-488D58FE-9A8B-4170-9B3D-07C463F1C89AQ36246347-6661AEF0-9F9B-4036-93F8-FDFE09076B66Q36613915-9D1BA13E-A89E-4656-ACAF-EE552FD27D45Q36614695-A21235C7-1B78-45DF-9800-59AC89F3EDFAQ36651159-8D003034-AB18-49F0-AC81-5584F788DC4FQ36679115-CCB4DAAC-B2AA-41AB-8F6E-D40927059535Q36704975-78B9F54F-A2FD-47AB-8523-912A8EDA0A77Q36715448-AD2FBD1F-D079-4607-9E45-DE93C6CFC727Q36884340-5F76BC52-3E3A-4469-A659-8BE091C3E828Q36969463-B822EAA1-C57E-4ACC-A60B-33FFEE55A1D8
P2860
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
description
1965 nî lūn-bûn
@nan
1965 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1965 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1965年の論文
@ja
1965年論文
@yue
1965年論文
@zh-hant
1965年論文
@zh-hk
1965年論文
@zh-mo
1965年論文
@zh-tw
1965年论文
@wuu
name
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@ast
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@en
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@nl
type
label
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@ast
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@en
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@nl
prefLabel
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@ast
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@en
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@nl
P1476
INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
@en
P2093
P304
P577
1965-06-01T00:00:00Z